Clinical Trial Supply & Logistics Market by Services, Type, Phase, Therapeutic Area, End User

Description

List of Tables

The Global Clinical Trial Supply & Logistics Market is forecasted to grow significantly, with a projected USD 24.33 billion in 2023 at a CAGR of 7.74% and expected to reach a staggering USD 41.04 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Clinical Trial Supply & Logistics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Clinical Trial Supply & Logistics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Services, market is studied across Comparator Sourcing, Logistics & Distribution, Manufacturing, Packaging, Labeling, & Blinding, and Storage & Retention. The Logistics & Distribution is further studied across Cold Chain Distribution and Non-Cold Chain Distribution. The Manufacturing commanded largest market share of 43.47% in 2022, followed by Logistics & Distribution.

Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules. The Small Molecules commanded largest market share of 34.91% in 2022, followed by Biologic Drugs.

Based on Phase, market is studied across BA/ BE studies, Phase 1, Phase 2, Phase 3, and Phase 4. The Phase 3 commanded largest market share of 24.77% in 2022, followed by Phase 1.

Based on Therapeutic Area, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Dermatological Disorders, Digestive Disorders, ENT Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Nephrology, Oncology, Rare Diseases, and Respiratory Disorders. The Blood Disorders commanded largest market share of 12.91% in 2022, followed by Oncology.

Based on End User, market is studied across Contract Research Organisations (CROs), Medical Devices Companies, and Pharmaceutical & Biotechnology companies. The Pharmaceutical & Biotechnology companies commanded largest market share of 63.66% in 2022, followed by Contract Research Organisations (CROs).

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.21% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Clinical Trial Supply & Logistics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trial Supply & Logistics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Supply & Logistics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Supply & Logistics Market?

4. What is the competitive strategic window for opportunities in the Global Clinical Trial Supply & Logistics Market?

5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Supply & Logistics Market?

6. What is the market share of the leading vendors in the Global Clinical Trial Supply & Logistics Market?

7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Supply & Logistics Market?

Product Code: MRR-501246436332

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Clinical Trial Supply & Logistics Market, by Services, 2022 vs 2030
4.3. Clinical Trial Supply & Logistics Market, by Type, 2022 vs 2030
4.4. Clinical Trial Supply & Logistics Market, by Phase, 2022 vs 2030
4.5. Clinical Trial Supply & Logistics Market, by Therapeutic Area, 2022 vs 2030
4.6. Clinical Trial Supply & Logistics Market, by End User, 2022 vs 2030
4.7. Clinical Trial Supply & Logistics Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing Incidence of Chronic Diseases Globally
  - 5.1.1.2. Rising Government Funds to R&D Activities
  - 5.1.1.3. Globalization of Clinical Trials and Harmonization of Regulations
- 5.1.2. Restraints
  - 5.1.2.1. High Cost Associated With the Clinical Trials
- 5.1.3. Opportunities
  - 5.1.3.1. Rising Focus on Drug Development with the Launch of New Drugs
  - 5.1.3.2. Outsourcing of Clinical Trial Activity
- 5.1.4. Challenges
  - 5.1.4.1. Lack of Skilled Person to Operate Devices During Clinical Trials
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Clinical Trial Supply & Logistics Market, by Services

6.1. Introduction
6.2. Comparator Sourcing
6.3. Logistics & Distribution
- 6.3.1. Cold Chain Distribution
- 6.3.2. Non-Cold Chain Distribution
6.4. Manufacturing
6.5. Packaging, Labeling, & Blinding
6.6. Storage & Retention

7. Clinical Trial Supply & Logistics Market, by Type

7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small Molecules

8. Clinical Trial Supply & Logistics Market, by Phase

8.1. Introduction
8.2. BA/ BE studies
8.3. Phase 1
8.4. Phase 2
8.5. Phase 3
8.6. Phase 4

9. Clinical Trial Supply & Logistics Market, by Therapeutic Area

9.1. Introduction
9.2. Blood Disorders
9.3. Cardiovascular Diseases
9.4. CNS & Mental Disorders
9.5. Dermatological Disorders
9.6. Digestive Disorders
9.7. ENT Diseases
9.8. Immunology
9.9. Infectious Diseases
9.10. Metabolic Disorders
9.11. Nephrology
9.12. Oncology
9.13. Rare Diseases
9.14. Respiratory Disorders

10. Clinical Trial Supply & Logistics Market, by End User

10.1. Introduction
10.2. Contract Research Organisations (CROs)
10.3. Medical Devices Companies
10.4. Pharmaceutical & Biotechnology companies

11. Americas Clinical Trial Supply & Logistics Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Clinical Trial Supply & Logistics Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing